Want to Calculate Fair Value?
Enter Stock | Calculate Fair Value

Stock: PFE
Book Value Per Share: $15.89
EPS: $2.89
Diluted EPS TTM: $1.38
Dividend Per Share: 1.69
Dividend Yield: 6.89 %
Dividend Payout Ratio: 58%
Price To Sales Ratio TTM: 2.134
Price To Book Ratio: 1.476
PEG Ratio: 0.595
EV To EBITDA: 10.29
P/E Ratio: 16.99
Forward P/E Ratio: 8.03
Ex Dividend Date: 2025-05-09
Dividend Date: 2025-06-13
Current Price: $24.54
Previous Close: $24.84
52 Week Low: $20.53
52 Week High: $29.98
Earning Date (within 30 days): N/A
50 Day MA: $23.46
200 Day MA: $26.32
Link to Yahoo (Financial): PFE
 
* Note: Prices are in Million (M) USD.
Description:
Pfizer Inc (PFE) ▼
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than 1 billion USD in annual revenues.
These criteria used Company’s Cash, EBITDA and Debt balance to determines its fair value:
Cash : $1,043 M
Debt : $56,703 M
EBITDA : $23,321 M
Net Debt (Debt - Cash): $55,660 M

Since Net Debt is covered by EBITDA within 3 years, 1 points assigned.
This criteria used industry in which company operates:
Sector: Healthcare
Industry: Drug Manufacturers - Major

Based on industry, 3 points assigned.
This criteria used Company’s Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 8.49

Since Forward PE Ratio is less than 15, 5 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $14,717 M
Average Revenue: $57,353 M
Free Cash Flow to Revenue : 26 %

Since Free Cash Flow (FCF) to Revenue percentage is greater than 25, 5 points assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $63,627 M
Revenue 4 Years Ago (2020-12-31): $41,908 M
Last 5 Years Average Revenue Growth: 10%

Since Revenue Growth is between 10 - 15, 3 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $5,700 M
Share Count 5 Years Ago (2020-12-31): $5,632 M

Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Earnings Per Share (EPS): $2.89
Dividend Per Share (DPS): $2
Payout Ratio: 58%
Dividend Yield: 7%

Since company Payout Ratio is greater than 50, 1 point assigned.

Since Dividend Yield is greater than 5, 5 points assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: 17%

Since Average ROE is between 10 - 20, 3 points assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $25
52-Week Low: $21
Threshold Price (15% Above 52-Week Low): $24

Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $133,322 M

Since Market Cap is between 100B - 500B, 3 points assigned.
% Exposure to Total Portfolio
Based on the calculated score, we recommend do not exceed 4% exposure of Total Portfolio.
Value-Trade has assigned 29 points to above Pfizer Inc (PFE) stock.
Twenty Years Avg PE 12, Fair Value PE 15, Industry Based PE is 14 and Growth based PE is 10. Based on these all values average assigned is 12.75.
Value-Trades has assined P/E value 12.75. Since current year earning per share is $2.89.
The fair value of Pfizer Inc (PFE) stock should be (12.75 x $2.89) = $36.85

Share this valuation:


Advertisement